Amgen multidistrict litigation transferred to New Jersey federal court
MLex Summary: The US Judicial Panel on Multidistrict Litigation has granted Amgen's motion to centralize its four patent infringement suits over denosumab, used in bone drugs Prolia and XGEVA. The panel...To view the full article, register now.
Already a subscriber? Click here to view full article